|Bid||137.86 x 100|
|Ask||138.37 x 100|
|Day's Range||135.72 - 138.17|
|52 Week Range||96.93 - 138.17|
|PE Ratio (TTM)||51.72|
|Earnings Date||Jul 27, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||143.09|
Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future.
With big biotechs Celgene and Gilead Sciences, it's a battle of growth stock versus income/value stock.
IBD's 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?